Interchangeable insulins - New pathways for safe, effective, affordable diabetes therapy

Research output: Contribution to journalReview article

Abstract

Draft FDA guidance would reduce barriers to marketing high-quality generic insulin in the United States by declaring that the evidence necessary for proving an insulin product "highly similar" to an existing product is sufficient for designating it as interchangeable.

Original languageEnglish (US)
Pages (from-to)981-983
Number of pages3
JournalNew England Journal of Medicine
Volume382
Issue number11
DOIs
StatePublished - Mar 12 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Interchangeable insulins - New pathways for safe, effective, affordable diabetes therapy'. Together they form a unique fingerprint.

  • Cite this